Glucosamine Use Linked to Accelerated Alzheimer's Progression and Dementia Risk
ScienceDaily Mind ·
·
1 min read ·
Humanities
Read research and analysis on Glucosamine Use Linked to Accelerated Alzheimer's Progression and Dementia Risk published by ICANEWS, a global research journal for emerging researchers.
Key Takeaways
Glucosamine use linked to faster progression from mild cognitive impairment to Alzheimer's disease.
25% higher likelihood of developing dementia among glucosamine users.
Biological clues identified that may explain the observed link.
Why This Matters
The findings suggest a potential adverse association between a popular supplement and cognitive health, specifically regarding dementia risk and Alzheimer's progression. This could be relevant for individuals using glucosamine, particularly those with mild cognitive impairment.
Overview
A study suggests an association between the use of glucosamine, a joint pain supplement, and accelerated progression from mild cognitive impairment to Alzheimer’s disease. The research indicated a 25% higher likelihood of developing dementia among individuals using glucosamine and identified potential biological mechanisms to explain this observation.
Research Context
Glucosamine is a widely used supplement for joint pain. The study aimed to investigate its potential relationship with cognitive decline, specifically focusing on the progression to Alzheimer's disease from mild cognitive impairment and the overall risk of dementia.
Findings
Glucosamine use was linked to a 25% higher likelihood of developing dementia.
The study suggested a connection between glucosamine use and faster progression from mild cognitive impairment to Alzheimer’s disease.
Biological clues were identified that may provide an explanation for the observed link.